Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 88 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| NANOPHASE TECHNOLOGIES CORPORATION | 30,373,270 | reported | 29 May 2025 | tx 443+63,041,581−24,571,854 |
| Clearside Biomedical, Inc. | 4,495,034 | reported | 07 Feb 2024 | tx 17+2,304,511−420,285 |
| ULTRALIFE CORP | 2,050,637 | reported | 26 May 2026 | tx 211+10,621,959−8,452,283 |
| SILVERLEAF RESORTS INC | 1,175,824 | reported | 10 May 2011 | tx 145+2,131,529−6,241,313 |
| SUNTERRA CORP | 303,155 | reported | 15 Oct 2003 | tx 13−4,443,200 |
| ISCO INTERNATIONAL INC | 0 | reported | 22 Aug 2008 | tx 3 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 21 May 2026 | PURCHASE | ULTRALIFE CORP | 32,876 | 6.13 USD | |
| 22 May 2026 | PURCHASE | ULTRALIFE CORP | 8,700 | 6.33 USD | |
| 26 May 2026 | PURCHASE | ULTRALIFE CORP | 67,302 | 6.81 USD | |
| 13 Mar 2026 | PURCHASE | ULTRALIFE CORP | 100,640 | 6.32 USD | |
| 16 Mar 2026 | PURCHASE | ULTRALIFE CORP | 53,131 | 6.76 USD | |
| 12 Mar 2026 | PURCHASE | ULTRALIFE CORP | 33,741 | 5.97 USD | |
| 16 Dec 2025 | PURCHASE | ULTRALIFE CORP | 28,588 | 5.70 USD | |
| 15 Dec 2025 | PURCHASE | ULTRALIFE CORP | 14,882 | 5.66 USD | |
| 12 Dec 2025 | PURCHASE | ULTRALIFE CORP | 9,530 | 5.63 USD | |
| 19 Nov 2025 | PURCHASE | ULTRALIFE CORP | 53,900 | 4.97 USD | |
| 20 Aug 2025 | PURCHASE | ULTRALIFE CORP | 13,000 | 6.57 USD | |
| 19 Aug 2025 | PURCHASE | ULTRALIFE CORP | 15,898 | 6.56 USD | |
| 21 Aug 2025 | PURCHASE | ULTRALIFE CORP | 29,766 | 6.63 USD | |
| 13 Jun 2025 | PURCHASE | ULTRALIFE CORP | 10,000 | 7.64 USD | |
| 29 May 2025 | SALE | NANOPHASE TECHNOLOGIES CORPORATION | 2,500,000 | 4.20 USD | |
| 29 May 2025 | PURCHASE | NANOPHASE TECHNOLOGIES CORPORATION | 4,189,000 | 4.20 USD | anomaly |
| 29 May 2025 | PURCHASE | NANOPHASE TECHNOLOGIES CORPORATION | 2,500,000 | 4.20 USD | anomaly |
| 29 May 2025 | SALE | NANOPHASE TECHNOLOGIES CORPORATION | 4,189,000 | 4.20 USD | |
| 23 May 2025 | PURCHASE | ULTRALIFE CORP | 11,980 | 5.41 USD | |
| 13 May 2025 | PURCHASE | ULTRALIFE CORP | 8,957 | 5.40 USD | first after silence |
| 15 May 2025 | PURCHASE | ULTRALIFE CORP | 2,140 | 5.72 USD | |
| 14 May 2025 | PURCHASE | ULTRALIFE CORP | 16,063 | 5.47 USD | |
| 25 Jun 2024 | CONVERSION | NANOPHASE TECHNOLOGIES CORPORATION | 15,000,000 | 0.00 USD | |
| 01 Mar 2024 | PURCHASE | NANOPHASE TECHNOLOGIES CORPORATION | 15,000 | 400.00 USD | deriv |
| 08 Feb 2024 | PURCHASE | NANOPHASE TECHNOLOGIES CORPORATION | 6,337 | 0.40 USD |
5 purchases reported after at least 12 months of silence — most recent on 13 May 2025.